A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype
Open Access
- 6 March 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Virology Journal
- Vol. 10 (1), 74
- https://doi.org/10.1186/1743-422x-10-74
Abstract
Background: The ability to deliver a gene of interest into a specific cell type is an essential aspect of biomedical research. Viruses can be a useful tool for this delivery, particularly in difficult to transfect cell types. Adeno-associated virus (AAV) is a useful gene transfer vector because of its ability to mediate efficient gene transduction in numerous dividing and quiescent cell types, without inducing any known pathogenicity. There are now a number of natural for that designed AAV serotypes that each has a differential ability to infect a variety of cell types. Although transduction studies have been completed, the bulk of the studies have been done in vivo, and there has never been a comprehensive study of transduction ex vivo/in vitro. Methods: Each cell type was infected with each serotype at a multiplicity of infection of 100,000 viral genomes/cell and transduction was analyzed by flow cytometry + . Results: We found that AAV1 and AAV6 have the greatest ability to transduce a wide range of cell types, however, for particular cell types, there are specific serotypes that provide optimal transduction. Conclusions: In this work, we describe the transduction efficiency of ten different AAV serotypes in thirty-four different mammalian cell lines and primary cell types. Although these results may not be universal due to numerous factors such as, culture conditions and/ or cell growth rates and cell heterogeneity, these results provide an important and unique resource for investigators who use AAV as an ex vivo gene delivery vector or who work with cells that are difficult to transfect.Keywords
This publication has 58 references indexed in Scilit:
- Gene Correction by Homologous Recombination With Zinc Finger Nucleases in Primary Cells From a Mouse Model of a Generic Recessive Genetic DiseaseMolecular Therapy, 2010
- Engineering of Human Pluripotent Stem Cells by AAV-mediated Gene TargetingMolecular Therapy, 2010
- Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene deliveryGene Therapy, 2010
- Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repairGene Therapy, 2010
- Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood–Brain Barrier (BBB)Molecular Therapy, 2010
- Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscleNature Biotechnology, 2010
- Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following TransductionMolecular Therapy, 2010
- DNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral ProgenyMolecular Therapy, 2008
- Highly Efficient, Functional Engraftment of Skeletal Muscle Stem Cells in Dystrophic MusclesCell, 2008
- Designer Gene Delivery Vectors: Molecular Engineering and Evolution of Adeno-Associated Viral Vectors for Enhanced Gene TransferPharmaceutical Research, 2007